TrialJournal of clinical hypertension (Greenwich, Conn.)2011

Treating systolic hypertension in the very elderly with valsartan-hydrochlorothiazide vs. either monotherapy: ValVET primary results.

Joseph L Izzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.